- Home
- EVGN vs CMMB Comparison
EVGN vs CMMB Comparison
Compare EVGN & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- CMMB
- Stock Information
- Founded
- EVGN 1999
- CMMB 2004
- Country
- EVGN Israel
- CMMB Israel
- Employees
- EVGN N/A
- CMMB N/A
- Industry
- EVGN Agricultural Chemicals
- CMMB Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- CMMB Health Care
- Exchange
- EVGN Nasdaq
- CMMB Nasdaq
- Market Cap
- EVGN 9.7M
- CMMB N/A
- IPO Year
- EVGN N/A
- CMMB N/A
- Fundamental
- Price
- EVGN $1.35
- CMMB $1.68
- Analyst Decision
- EVGN Strong Buy
- CMMB Strong Buy
- Analyst Count
- EVGN 1
- CMMB 3
- Target Price
- EVGN $12.00
- CMMB $7.33
- AVG Volume (30 Days)
- EVGN 58.6K
- CMMB 87.4K
- Earning Date
- EVGN 11-21-2024
- CMMB 11-14-2024
- Dividend Yield
- EVGN N/A
- CMMB N/A
- EPS Growth
- EVGN N/A
- CMMB N/A
- EPS
- EVGN N/A
- CMMB N/A
- Revenue
- EVGN $7,478,000.00
- CMMB N/A
- Revenue This Year
- EVGN $90.35
- CMMB N/A
- Revenue Next Year
- EVGN $38.71
- CMMB N/A
- P/E Ratio
- EVGN N/A
- CMMB N/A
- Revenue Growth
- EVGN 30.69
- CMMB N/A
- 52 Week Low
- EVGN $1.20
- CMMB $0.45
- 52 Week High
- EVGN $10.40
- CMMB $2.55
- Technical
- Relative Strength Index (RSI)
- EVGN 36.47
- CMMB 52.44
- Support Level
- EVGN $1.20
- CMMB $1.53
- Resistance Level
- EVGN $1.49
- CMMB $1.71
- Average True Range (ATR)
- EVGN 0.12
- CMMB 0.11
- MACD
- EVGN 0.01
- CMMB -0.01
- Stochastic Oscillator
- EVGN 35.71
- CMMB 39.47
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.